Subcutaneous Immunoglobulin Replacement Therapy in Patients with Primary Immunodeficiency in Routine Clinical Practice: The VISPO Prospective Multicenter Study

BACKGROUND AND OBJECTIVES: Subcutaneous immunoglobulin (SCIG) therapy is becoming increasingly popular as self-administration is possible because intravenous access is unnecessary, and there is a lower frequency of systemic adverse events. The aim of this study was to evaluate the shifting from intr...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:Clin Drug Investig
المؤلفون الرئيسيون: Vultaggio, Alessandra, Azzari, Chiara, Milito, Cinzia, Finocchi, Andrea, Toppino, Claudia, Spadaro, Giuseppe, Trizzino, Antonino, Baldassarre, Martire, Paganelli, Roberto, Moschese, Viviana, Soresina, Annarosa, Matucci, Andrea
التنسيق: Artigo
اللغة:Inglês
منشور في: Springer International Publishing 2015
الموضوعات:
Original Research Article
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC4335091/
https://ncbi.nlm.nih.gov/pubmed/25672929
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40261-015-0270-1
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة